Complicações pulmonares em pacientes diabéticos com infecção por covid-19 / Pulmonary complications in diabetic patientes with covid-19 infection

Mateus Camargos Silva Alves Simão, Júlia Fraga Castro e Oliveira, Emanuela Carvalho Rodrigues, Fernanda Tavares de Oliveira, João Marcos Batista Gomes de Araujo, Julia Raquel Felipe Caldeira, Mariana Campos Martins, Nicolli Barreto Rosa Piontkowski, Túlio Esteves Tormin Botelho, Adriel Gustavo Lopes

Abstract


INTRODUÇÃO: A COVID-19 se tornou uma preocupação mundial de saúde pública devido à sua rápida disseminação, instalando uma pandemia. Vários estudos indicaram o Diabetes mellitus contribuindo com um risco aumentado para eventos pulmonares graves. O objetivo do artigo é discutir as complicações respiratórias presentes em pacientes diabéticos infectados pelo SARS-CoV-2. METODOLOGIA: Pesquisa bibliográfica realizada selecionando estudos publicados nos últimos cinco anos pelos bancos de dados PubMed, Scielo e BVS MS. RESULTADOS: Observou-se que pacientes diabéticos com COVID-19 têm mais chance de ter um envolvimento pulmonar  grave. Além disso, esses pacientes possuem maior probabilidade de desenvolver um quadro de pneumonia grave. DISCUSSÃO: Devido ao processo inflamatório generalizado, inerente a Diabetes Mellitus (DM), é necessário um manejo especial desses pacientes perante a uma infecção por SARS-CoV-2. Uma resposta imunológica já desencadeada pela DM, somada a tempestade de citocinas causada pelo vírus, ocasiona uma resposta tecidual deletéria sistêmica. CONCLUSÃO: Um protocolo de manejo para casos de SARS-CoV-2 em pacientes portadores de diabetes deve ser feito, devido à alta prevalência de complicações sistêmicas das duas anomalias  concomitantes.

 

 


Keywords


Diabetes Mellitus, Infecção por Coronavirus, SARS-CoV, Complicações e Prognóstico.

References


ABU-FARHA, Mohamed et al. Impact of Diabetes in Patients Diagnosed With COVID-19. Frontiers In Immunology. [S. L.], p. 1-11. dez. 2020.

ANGHEBEM, Mauren Isfer; REGO, Fabiane Gomes de Moraes; PICHETH, Geraldo. COVID-19 and Diabetes: two distinct pandemics and their relationship. Revista Brasileira de Analises Clinicas, ago. 2020.

AQUINO, Pedro Augusto Grossi Quintão et al. Influência do DM2 e do controle glicêmico no prognóstico de pacientes infectados por COVID-19. Brazilian Journal Of Health Review. Curitiba, p. 11120-11130. ago. 2020.

AZAR, William S. et al. COVID-19 and diabetes mellitus: how one pandemic worsens the other. Reviews In Endocrine & Metabolic Disorders, v. 21, n. 04, p. 451-463, out. 2020.

CHEE, Ying Jie et al. Dissecting the interaction between COVID-19 and diabetes mellitus. Journal Of Diabetes Investigation. Singapore, p. 1-11. jun. 2020.

FANG, Lei; KARAKIULAKIS, George; ROTH, Michael. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine, [S.L.], v. 8, n. 4, abr. 2020.

GUO, Weina et al. Diabetes is a risk factor for the progression and prognosis of COVID‐19. Diabetes/metabolism Research And Reviews, v. 36,31 mar. 2020.

HUSSAIN, Akhtar et al. COVID-19 and diabetes: Knowledge in progress. Diabetes Research And Clinical Practice. Bodo, p. 1-10. abr. 2020.

KHALILI, Shayesteh et al. Comparison of Mortality Rate and Severity of Pulmonary Involvement in Coronavirus Disease-2019 Adults Patients With and Without Type 2 Diabetes. Canadian Journal Of Diabetes, nov. 2020. Elsevier BV.

KUMAR, Ashish et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes & metabolic syndrome vol. 14, n. 4, p. 535-545. maio 2020.

LOUREIRO, Camila Melo Coelho et al. Alterações Pulmonares na COVID-19. Revista Científica Hospital Santa Izabel, [s. l], v. 4, n. 2, p. 89-98, ago. 2020.

MAVEDDAT A, Mallah H, Rao S, Ali K, Sherali S, Nugent K. Severe acute respiratory distress syndrome secondary to coronavirus 2 (SARS-CoV-2). Int J Occup Environ Med. 2020;11(4):157-178.

MUNIYAPPA, Ranganath; GUBBI, Sriram. COVID-19 pandemic, coronaviruses, and diabetes mellitus. American Journal Of Physiology-Endocrinology And Metabolism, [S.L.], v. 318, n. 5, p. 736-741, 1 maio 2020.

Nandy K, Salunke A, Pathak SK, et al. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):1017-1025.

PARVEEN R, Sehar N, Bajpai R, Agarwal NB. Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis. Diabetes Res Clin Pract. 2020;166(January):108295. doi:10.1016/j.diabres.2020.108295

PITITTO, Bianca de Almeida; FERREIRA, Sandra Roberta G.. Diabetes and covid-19: more than the sum of two morbidities. Rev. Saúde Pública, São Paulo, v. 54, 54, 2020.

SCHEEN, A J; MARRE, M; THIVOLET, C. Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports. Diabetes & Metabolism, v. 46, n. 4, p. 265-271, 21 maio 2020.

SINGH, Awadhesh Kumar et al. “Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.” Diabetes & metabolic syndrome vol. 14, n. 04,p. 303-310. ago. 2020.

YAN, Yimin et al. Analysis of clinical features and pulmonary CT features of coronavirus disease 2019 (COVID-19) patients with diabetes mellitus. Endokrynologia Polska, Kkk, v. 71, n. 5, p. 367-375, 18 set. 2020.

YAN, Yongli et al. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. Bmj Open Diab Research Care. Wuhan, p. 1-9. abr. 2020.

SHRESTHA, Ekta et al. Type 2 diabetes is associated with increased risk of critical respiratory illness in patients COVID-19 in a community hospital. Elsevier Public Health Emergency Collection, 30 dec. 2020.

DAS, Subham et al. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review. Elsevier Public Health Emergency Collection. Epub 2020 Aug 3.




DOI: https://doi.org/10.34119/bjhrv4n2-051

Refbacks

  • There are currently no refbacks.